FIELD: medicine, pharmacy. SUBSTANCE: invention proposes a novel pharmaceutical composition for oral administration of molecular iodine and methods for its administration. The composition represents combination of iodine anion with certain oxidizing agent or iodine cation with certain reducing agent being weight ratio of iodide anion to iodate anion (I-/IO) is 0.78-6.0. Molecular iodine is formed in stomach in the controlled ratio of molecular iodine to the total iodine content exceeding at least 0.80 of theoretically expected maximal yield. Invention allows preparing the stable pharmaceutical composition and to control dose of releasing molecular iodine. EFFECT: improved preparing and administration methods, reduced adverse by-side effects. 20 cl, 1 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY ACTIVE FOOD ADDITIVE CONTAINING NON-IONIC FORMS OF IODINE AND SELENIUM | 2021 |
|
RU2765999C1 |
METHOD OF PREVENTION OF LESIONS CAUSED BY IODIN RADIONUCLIDES AND OPTIMISATION OF IODIN METABOLISM IN POST-PREVENTIVE PERIOD | 2002 |
|
RU2323733C2 |
METHOD AND PREPARATION FOR PREVENTING DAMAGE BY RADIONUCLIDES OF IODINE TO A HUMAN OR ANIMAL BODY | 2022 |
|
RU2796757C1 |
SOILENT TOPICAL DISINFECTANTS | 2017 |
|
RU2813594C2 |
TREATING A HEART ATTACK AND ISCHEMIC INJURY WITH HALOGEN COMPOUNDS | 2015 |
|
RU2728790C2 |
ANTI-ESTROGENIC AND ANTI-PROLIFERATIVE AGENT FOR TREATMENT AND PROPHYLAXIS OF FEMALE REPRODUCTIVE SYSTEM DISEASES | 2006 |
|
RU2315594C1 |
NOVEL COMPOUNDS | 1997 |
|
RU2184113C2 |
AGENT FOR TREATMENT AND PROPHYLAXIS SICKNESSES CAUSED BY IODINE DEFICIENCY | 1992 |
|
RU2110265C1 |
METHOD FOR PRODUCING DRUG USED FOR TREATING GASTROINTESTINAL ULCER IN MAMMALS | 1990 |
|
RU2020931C1 |
METHOD FOR PREPARING MICROELEMENT DRUG BASED ON IRON-DEXTRIN COMPLEX | 2009 |
|
RU2409375C1 |
Authors
Dates
2003-10-10—Published
1998-10-27—Filed